Showing results (31-40 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|April 2, 2021
Volume matters and intensification is needed: emerging trends in the management of advanced prostate cancerIris Y Sheng, Pedro Barata, Raafat Alameddine, et al.Drugs in Context|July 9, 2020
Can vitamins and/or supplements provide hope against coronavirus?Sarah M Michienzi, Melissa E BadowskiDrugs in Context|April 3, 2015
Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patientsSiddhesh A Kamat, Steve Offord, John Docherty, et al.Drugs in Context|April 20, 2023
Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcetMuhammed Ahmed Elhadedy, Ghada El-Kannishy, Ayman F Refaie, et al.Drugs in Context|April 20, 2023
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experienceGiacomo Caldarola, Arianna Zangrilli, Gerardo Palmisano, et al.Drugs in Context|July 14, 2020
Coronavirus disease 2019 (COVID-19): latest developments in potential treatmentsKam Lun Hon, Karen Ka Yan Leung, Alexander Kc Leung, et al.Drugs in Context|July 24, 2020
Comparison of modafinil and pitolisant in narcolepsy: a non-inferiority meta-analytical approachPhilippe Lehert, Cassandra SzoekeDrugs in Context|July 24, 2020
Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trialJosé Luis Hernández, Francisco S Lozano, Vincent Riambau, et al.Drugs in Context|April 8, 2021
Paediatrics: how to manage scabiesRussell Thompson, Sean Westbury, Dana SlapeDrugs in Context|November 7, 2019
Upadacitinib and filgotinib: the role of JAK1 selective inhibition in the treatment of rheumatoid arthritisMartina Biggioggero, Andrea Becciolini, Chiara Crotti, et al.Pageof 56